Asthma Drug Linked to Suicide Risks: Parents Alarmed
Submitted by MAGA
Posted 2 hours ago
**Dangerous Silence: New Study Links Popular Asthma Drug to Suicide Risks**
A groundbreaking study has unveiled alarming connections between the widely prescribed asthma medication montelukast, known as Singulair, and severe psychiatric side effects, including suicidal thoughts.
Research backed by government efforts has revealed a concerning trend that affects millions of Americans.
Montelukast, which is prescribed to around 12 million people, including 1.6 million children, has been linked to serious mental health issues ranging from depression to hallucinations.
This comes as further evidence highlights that the medication interacts with brain cells involved in mood regulation and impulse control.
The FDA has already added a black box warning to montelukast, indicating potential risks of death or serious harm associated with its use.
Despite these warnings, the drug continues to be prescribed at significant rates, raising questions about the responsibility of medical professionals and the pharmaceutical industry in communicating these risks.
Parents across the nation are increasingly concerned as tragic stories of children experiencing these side effects emerge.
One heart-wrenching case involved a child who attempted suicide merely days after starting the medication.
The FDA has received over 80 suicide cases linked to montelukast since 1998, with a significant number involving young patients.
Experts have urged the FDA to take further action and ensure that physicians inform their patients about these potentially life-threatening side effects.
Currently, the FDA has no plans to update the drug's label further, leaving many families feeling vulnerable and anxious about the safety of a medication they believed to be benign.
As the conversation around drug safety becomes more urgent, many are calling for greater transparency from both the pharmaceutical companies and regulatory agencies involved.
Parents advocating for their children's health need to be fully equipped with the risks associated with medications like montelukast, especially in light of new revelations.
This study serves as a crucial reminder that the health and well-being of our most vulnerable, particularly our children, should always come first.
Sources:
cowboystatedaily.com
thegatewaypundit.com
dailymail.co.uk
A groundbreaking study has unveiled alarming connections between the widely prescribed asthma medication montelukast, known as Singulair, and severe psychiatric side effects, including suicidal thoughts.
Research backed by government efforts has revealed a concerning trend that affects millions of Americans.
Montelukast, which is prescribed to around 12 million people, including 1.6 million children, has been linked to serious mental health issues ranging from depression to hallucinations.
This comes as further evidence highlights that the medication interacts with brain cells involved in mood regulation and impulse control.
The FDA has already added a black box warning to montelukast, indicating potential risks of death or serious harm associated with its use.
Despite these warnings, the drug continues to be prescribed at significant rates, raising questions about the responsibility of medical professionals and the pharmaceutical industry in communicating these risks.
Parents across the nation are increasingly concerned as tragic stories of children experiencing these side effects emerge.
One heart-wrenching case involved a child who attempted suicide merely days after starting the medication.
The FDA has received over 80 suicide cases linked to montelukast since 1998, with a significant number involving young patients.
Experts have urged the FDA to take further action and ensure that physicians inform their patients about these potentially life-threatening side effects.
Currently, the FDA has no plans to update the drug's label further, leaving many families feeling vulnerable and anxious about the safety of a medication they believed to be benign.
As the conversation around drug safety becomes more urgent, many are calling for greater transparency from both the pharmaceutical companies and regulatory agencies involved.
Parents advocating for their children's health need to be fully equipped with the risks associated with medications like montelukast, especially in light of new revelations.
This study serves as a crucial reminder that the health and well-being of our most vulnerable, particularly our children, should always come first.
Sources:
cowboystatedaily.com
thegatewaypundit.com
dailymail.co.uk
Latest News